Filing Flows › Sanofi (SNY) › Q1 2026
Sanofi (SNY) Q1 2026 earnings results (first quarter 2026)
6-K filed Apr 23, 2026
Sanofi (SNY) reported revenue of $10.5B for the first quarter 2026 (Q1 2026), +6% from a year earlier. Operating margin was 20.2%, net earnings $1.6B (15.4% of revenue).
Sanofi, Q1 2026: revenue $10.5B (+6% year over year), operating margin 20.2%, net earnings $1.6B, operating cash flow $1.7B. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $10.5B | — | +6% |
| Gross profit | $8.1B | — | +5% |
| Operating profit | $2.1B | — | -7% |
| Net earnings | $1.6B | — | -14% |
| Operating cash flow | $1.7B | — | -20% |
What changed
Revenue was €10.5B in Q1 2026, up 6% year over year.
Gross margin was 77.1%, down 0.9 points from a year earlier. Operating profit was €2.1B, a 20.2% margin (down 2.9 points year over year). Operating profit fell €0.16B even though revenue rose €0.61B versus a year earlier, so costs grew faster than sales. Operating expenses grew 10% against revenue growth of 6%. The fastest-growing cost line was Other operating costs (+17%). Net earnings were €1.6B, down 14% year over year. The effective tax rate was -35.0%.
Operating cash flow was €1.7B (down 20% year over year), 104% of net earnings.
Questions
What was Sanofi's revenue in the first quarter 2026?
Sanofi (SNY) reported revenue of $10.5B for the first quarter 2026 (Q1 2026), +6% from a year earlier.
Was Sanofi profitable in the first quarter 2026?
Operating profit was $2.1B (20.2% of revenue) and net earnings $1.6B.
Source: Sanofi 6-K on SEC EDGAR.